Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial

Maria Pabon, Brian L. Claggett, Xiaowen Wang, Zi Michael Miao, Safia Chatur, Ankeet S. Bhatt, Muthiah Vaduganathan, James C. Fang, Akshay S. Desai, Pardeep Jhund, Felipe Martinez, Rudolf A. de Boer, Mikhail N. Kosiborod, Carolyn S.P. Lam, Sanjiv J. Shah, Adrian F. Hernandez, John J.V. McMurray, Scott D. Solomon, Orly Vardeny

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science